Head And Neck Cancer And Immunotherapy With Dr. Nabil F. Saba

Head and Neck Cancer and Immunotherapy with Dr. Nabil F. Saba

Cancer Research Institute

Winship Grand Rounds September 28, 2016: Nabil Saba, MD

Winship Cancer Institute of Emory University

Dr. Saba on Immunotherapy/Radiation Combo in Head and Neck Cancer

ASCO Memphis 2024 | Head and Neck Cancer

Total Health | Oncology

Dr. Saba on the Future of Head and Neck Cancer Treatment

Immunotherapy in advanced head and neck cancer

Winship Cancer Institute of Emory University

Head and Neck Cancer and Immunotherapy with Dr. Trisha Wise-Draper

Cancer Research Institute

Updates in the Management of Thyroid Cancer Virtual Symposium Presentation - Nabil Saba, MD

Winship Cancer Institute of Emory University

Novel immunotherapy approaches in metastatic head and neck cancer

Dr. Saba on Emerging Sequencing Strategies in Head and Neck Cancer

Head and neck updates at ASCO 2023

Dr. Saba on Scheduling Challenges With Cisplatin in Head and Neck Cancer

Nivolumab-Related Efficacy and Toxicity in HNSCC Patients

Momentum in Head and Neck Cancer Immunotherapy, with Jonathan Schoenfeld

Cancer Research Institute

Transforming Nasopharyngeal Carcinoma Care: The Role of Immunotherapy

Pembrolizumab for Recurrent HNSCC

AHEAD-MERIT: first-line pembrolizumab and BNT113 in advanced HPV16+ HNSCC

Building on the Immunotherapy Foundation for Head and Neck Cancer

PeerView Oncology

Immunotherapy Treatments in Patients with Head and Neck Cancer - ASCO Recaps Head and Neck Cancer

GRACE - Global Resource for Advancing Cancer Education

How COVID-19 Has Changed the Way We Approach Head & Neck Cancer Care